Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.
Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, Goff L, Gupta S, Guy J, Harris WP, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Knox JJ, Kortmansky J, Leaf A, Remak WM, Shroff RT, Sohal DPS, Taddei TH, Venepalli NK, Wilson A, Zhu AX, Rose MG. Gordan JD, et al. J Clin Oncol. 2020 Dec 20;38(36):4317-4345. doi: 10.1200/JCO.20.02672. Epub 2020 Nov 16. J Clin Oncol. 2020. PMID: 33197225 Clinical Trial.
"And what other medications are you taking?".
Gordan JD, Chay WY, Kelley RK, Ko AH, Choo SP, Venook AP. Gordan JD, et al. J Clin Oncol. 2011 Apr 10;29(11):e288-91. doi: 10.1200/JCO.2010.32.8054. Epub 2011 Jan 18. J Clin Oncol. 2011. PMID: 21245436 No abstract available.
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach.
Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK. Kastenhuber ER, et al. Among authors: gordan jd. J Hepatocell Carcinoma. 2019 Jan 31;6:41-48. doi: 10.2147/JHC.S194764. eCollection 2019. J Hepatocell Carcinoma. 2019. PMID: 30951568 Free PMC article.
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
Abou-Alfa GK, Mayer R, Venook AP, O'Neill AF, Beg MS, LaQuaglia M, Kingham PT, Kobos R, Basturk O, Brennan C, Yopp A, Harding JJ, Leong S, Crown J, Hoti E, Leonard G, Ly M, Bradley M, Valentino E, Markowitz D, Zukiwski A, Ren K, Gordan JD. Abou-Alfa GK, et al. Among authors: gordan jd. Oncologist. 2020 Dec;25(12):e1837-e1845. doi: 10.1634/theoncologist.2020-0093. Epub 2020 Mar 10. Oncologist. 2020. PMID: 32154962 Free PMC article. Clinical Trial.
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
El Dika I, Mayer RJ, Venook AP, Capanu M, LaQuaglia MP, Kobos R, O'Neill AF, Chou JF, Ly M, Ang C, O'Reilly EM, Gordan JD, Abou-Alfa GK. El Dika I, et al. Among authors: gordan jd. Oncologist. 2020 Nov;25(11):925-e1603. doi: 10.1634/theoncologist.2020-0367. Epub 2020 May 26. Oncologist. 2020. PMID: 32400000 Free PMC article. Clinical Trial.
A framework for fibrolamellar carcinoma research and clinical trials.
Dinh TA, Utria AF, Barry KC, Ma R, Abou-Alfa GK, Gordan JD, Jaffee EM, Scott JD, Zucman-Rossi J, O'Neill AF, Furth ME, Sethupathy P. Dinh TA, et al. Among authors: gordan jd. Nat Rev Gastroenterol Hepatol. 2022 May;19(5):328-342. doi: 10.1038/s41575-022-00580-3. Epub 2022 Feb 21. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35190728 Free PMC article. Review.
67 results